Company news
China NT Pharma Group Co., Ltd. news in 2026
China NT Pharma Group Co., Ltd.'s news releases, calls and decks from 2026, newest first.
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
November 3, 2026
Quarterly updates on the implementation of action plans to resolve the disclaimer of opinion
October 30, 2026
Voluntary announcement in relation to the application for revocation of the first arbitral award and litigation in respect of the equity interest in beijing kangchen biological technology co., limited
October 30, 2026
Supplemental announcement supplemental information in relation to the annual report for the year ended 31 December 2025
October 23, 2026
Notification Letter and Request Form to Non-Registered Holder
October 20, 2026
Notification Letter and Reply Form to Registered Shareholder
October 20, 2026
Form of proxy for use at extraordinary general meeting
October 20, 2026
Notice of extraordinary general meeting
October 20, 2026
Appointment of auditor and notice of extraordinary general meeting
October 20, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
October 6, 2026
Notification Letter and Request Form to Non-Registered Holder
September 29, 2026
Notification Letter and Reply Form to Registered Shareholder
September 29, 2026
2026 Interim Report
September 29, 2026
Voluntary announcement in relation to the application for compulsory enforcement by a wholly-owned subsidiary in respect of the shareholders' right to information of beijing kangchen biological technology co., limited
September 25, 2026
Inside information announcement arbitration award
September 25, 2026
Appointment of auditor
September 14, 2026
Connected transaction in relation to loan capitalisation involving subscription of shares under Specific mandate
June 17, 2026
Supplemental announcement retirement of auditor
June 11, 2026